InMode is a small-cap medical device company that invented a new way to do plastic surgery in a non-invasive way, via radio waves. The company is dominating its niche market, and the stock is up ...

InMode, known for radiofrequency microneedling technology in cosmetic applications, faces a blend of market opportunities and financial challenges. INMD's innovative products like Morpheus8 and Evolve ...

Over the years, Israel has become increasingly acknowledged as one of the world's most innovative and rapidly-evolving tech hubs. However, while Isreal is known for exporting products such as ...

As CEO of InMode, I felt it was important to wait until after our earnings call on February 4, 2025, to respond comprehensively to the concerns raised in your recent communications. Over the past year ...

InMode Ltd INMD reported Q2 sales of $136.1 million, an increase of 20% Y/Y, beating the consensus of $132 million and slightly above the preliminary numbers. Adjusted EPS reached $0.72, compared to ...

InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio frequency ("RF") technology. InMode strives to enable ...

InMode INMD is preparing to release its quarterly earnings on Monday, 2025-04-28. Here's a brief overview of what investors should keep in mind before the announcement. Analysts expect InMode to ...

YOKNEAM, Israel, July 10, 2025 /PRNewswire/ --InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results ...

Starting with total revenue, InMode generated $86.4 million in the second quarter of 2024. However, pro forma revenue was $102.6 million, which includes pre-orders of new platforms not yet delivered.

The market for cosmetic surgery-related procedures is worth over $63 billion annually and is growing fast. InMode is gaining a share of the aesthetics market, with proprietary devices and workstations ...

Teladoc has recently put the focus on the path to profitability. InMode has delivered gains in earnings over time. Teladoc and InMode may offer investors a buying opportunity when it comes to price, ...